PT Multi Indocitra TBK operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Multi Indocitra TBK with three other
drug stores in Asia:
Sharehope Medicine Company Limited
sales of 1.72 billion Taiwanese Dollars [US$57.57 million]
of which 69%
was Medical Business),
of South Korea
(70.28 billion Korean Won [US$62.27 million]
Topsun Science And Technology
based in China
(228.93 million Chinese Renmimbi [US$37.32 million]
of which 100%
PT Multi Indocitra TBK reported sales of 465.31 billion Indonesian Rupiahs (US$47.00 million)
December of 2011.
increase of 9.9%
versus 2010, when the company's sales were 423.34 billion Indonesian Rupiahs.
Sales at PT Multi Indocitra TBK have increased during each of the previous five years
(and since 2006, sales have increased a total of 110%).